the main problem with Biotechs is that the majority fail to show...

the main problem with Biotechs is that the majority fail to show upward movement, and this scares investors off.

They are generally a pump and dump stock....

i can list a few over the past 24 months.

BTA, PGL, BLT, AVX.

if you dont have a complete understanding of biotechs and how they operate you probly shouldnt be bothering.

The news flow is slow, and it takes time.

The rewards can be substancial.

This is why biotechs are not included in managed funds. Theres no cash flow in most circumstances.

The capital raising can be painful...

i am talking about developing biotechs which PGL is.

good luck to those who stick at it.

definatley a long term stock, we could be looking at a $20 or $30 stock here in 5 years time. we see the potential, do you have the patience. Timing is important with biotechs.

SRX is one that is expected to be taken over...

thats the game.

live and learn. stiff about the 13k loss, did you have an exit price if you were to make a profit?